Thanks @ISNkidneycare @PAmarapurkar @SabineKaram6 for letting Dr @onconeph and I share some insights from the recently published Positions Statements on GFR assessment and ICI-AKI from the @onconephsociety . Check out the recorded webinar 👇🏽 @MayoClinicNeph

https://t.co/xRajHqv9ij please join us tomorrow at 4pm GMT for a passionate debate on kidney dysfunction associated with HIV in Tanzania. @SabineKaram6 @hiv @AfricanAFRAN @AnandhUrmila @DrOribaDan @rkalyes1 @graekan

Current criteria for Cisplatin Eligibility can lead to suboptimal estimation of kidney function and to suboptimal dosing

Why does Kidney Function Assessment Matter in Patients with Cancer? Live webinar @ISNeducation @ISNkidneycare @onconephsociety @onconeph @PAmarapurkar @HerrmannMd a thread

Why do the current criteria for Cisplatin Eligibility deprive a large percent of patients that are potentially eligible from treatment? Live webinar @ISNeducation @ISNkidneycare @onconephsociety @onconeph @PAmarapurkar @HerrmannMd

Why does Kidney Function Assessment Matter in Patients with Cancer? Live webinar happening now @ISNeducation @ISNkidneycare @onconephsociety with @onconeph @PAmarapurkar @HerrmannMd

New content online: Kidney diseases and the thyroid: interactions and consequences https://t.co/bzuMVJDdyv

🎥Explore the onconephrology case presentation series on the ISN Academy, in collaboration with @onconephsociety Tackle real-world challenges in cancer & kidney care. 📌 Latest case: Onco-hypertension 👉 https://t.co/w7IyWkCEtJ

Free registration through @ISNeducation great collaborative webinar between @onconephsociety and @ISNkidneycare with @PAmarapurkar @HerrmannMd @onconeph

Hi everyone! I’m Maulinkumar Patel, an IMG, Research Assistant at @UTHealthHouston, and Co-chair of website committee @onconephsociety improving onconephrology outreach/education. Thrilled to be applying to #internalmedicine for the #Match2026! AAMC: 16435351 @rc_oncneph

By young nephrologists, for young nephrologists! 🌍 Learn to design studies & interpret data with the ISN YNC Research Interpretation Course (now CME-accredited!) 🤩 #ISNyoung https://t.co/xgrb0uZqc3

Dr Prakash Shashikant Gudsoorkar on hormone therapy related HTN: new thing to talk about🗣️ @ASNKidney @onconephsociety #KidneyWk

On behalf of @ASNKidney @nkf @ASPNeph @KidneyPatients and @KidneyFund I’m proud to share #TKHR👇🏽 Transforming Kidney Health Research: A Research Agenda for the Future https://t.co/aZemEMP2j6

4️⃣ Shoutout to the @ISNkidneycare social media team 📱 Always a treat catching up with friends from around the world 🌍 @SabineKaram6 @RClaure_nefro And hoping @FerArceAmare approves the photos 😄✨ #KidneyWk

Great WIN Networking session today! Thank you all for those who came!

Disaster Nephrology: a global and increasing problem that needs coordination and solidarity @Abualfaa representing the @ISNkidneycare Renal Disaster Preparedness Committee efforts with @ASNKidney @ERAkidney

Insightful talk by @RangaswJ at #kidneywk. Risk depends on the lens. 🫘KFRE quantifies kidney failure risk 🫀PREVENT integrates cardiovascular and renal axes. Same eGFR and albuminuria can have profoundly different risk trajectories. The challenge for clinicians: balance

Curious how pediatric hypertension shapes cardiovascular and kidney health later in life? Don’t miss our @ASNKidney session on Thursday at 10.30 am with @asouth_neph @TammyBradyMD and Joyce Samuel. #KidneyWeek @IntPedHTN

Dr Susanne Nicholas will be giving the Nancy Gary Lecture this year during ASN kidney week. Come join us on Nov 7th 4.30-5.30pm CT.

1) Welcome to a new #accredited #tweetorial from @cardiomet_ce and @ckd_ce, addressing Phase 3 data from #ESC2025 on the first major advancement in #hypertension therapy in 20 years! We're talking about #aldosterone synthase inhibitors #ASI for difficult-to-control #HTN.